The resistance to TRAIL-induced apoptosis in BC is primarily driven by the downregulation of death receptors (DR4/DR5), overexpression of decoy receptors, and alterations in downstream apoptotic signaling components such as caspase-8 and FLIP [77]. The gene discussed is TNFSF10; the disease is breast cancer.